These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8016770)

  • 1. Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation.
    Jaeschke R; Guyatt GH; Willan A; Cook D; Harper S; Morris J; Ramsdale H; Haddon R; Newhouse M
    Thorax; 1994 May; 49(5):479-84. PubMed ID: 8016770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of increasing doses of beta-agonists on airflow in patients with chronic airflow limitation.
    Jaeschke R; Guyatt GH; Cook D; Morris J; Willan A; McIlroy W; Harper S; Ramsdale H; Haddon R; Fitzgerald MJ
    Respir Med; 1993 Aug; 87(6):433-8. PubMed ID: 8105519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of prolonged treatment with low and high doses of inhaled terbutaline on beta-adrenoceptor responsiveness in patients with chronic obstructive pulmonary disease.
    Lipworth BJ; Clark RA; Dhillon DP; McDevitt DG
    Am Rev Respir Dis; 1990 Aug; 142(2):338-42. PubMed ID: 2166455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of terbutaline on exercise capacity and pulmonary function in patients with chronic obstructive pulmonary disease.
    Iversen ET; Sørensen T; Heckscher T; Jensen JI
    Lung; 1999; 177(4):263-71. PubMed ID: 10384064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstruction.
    Mestitz H; Copland JM; McDonald CF
    Chest; 1989 Dec; 96(6):1237-40. PubMed ID: 2582827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.
    Weir DC; Burge PS
    Thorax; 1993 Apr; 48(4):309-16. PubMed ID: 8511727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease.
    Wijkstra PJ; TenVergert EM; van der Mark TW; Postma DS; Van Altena R; Kraan J; Koëter GH
    Thorax; 1994 May; 49(5):468-72. PubMed ID: 8016768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.
    Newnham DM; Dhillon DP; Winter JH; Jackson CM; Clark RA; Lipworth BJ
    Thorax; 1993 Nov; 48(11):1151-5. PubMed ID: 8296260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peroral terbutaline in the treatment of patients with severe irreversible obstructive pulmonary disease].
    Maltbaek N; Christensen HR; Garsdal P; Bro H; Rasmussen FV
    Ugeskr Laeger; 1990 Mar; 152(11):729-32. PubMed ID: 2181755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of inhaled terbutaline on FEV1, FVC, dyspnoea and walking distance in patients with chronic obstructive lung disease.
    Evald T; Keittelmann S; Sindrup JH; Lange P
    Respir Med; 1992 Mar; 86(2):93-6. PubMed ID: 1615190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease.
    Grove A; Lipworth BJ; Reid P; Smith RP; Ramage L; Ingram CG; Jenkins RJ; Winter JH; Dhillon DP
    Thorax; 1996 Jul; 51(7):689-93. PubMed ID: 8882074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response study of inhaled salbutamol powder in chronic airflow obstruction.
    Corris PA; Neville E; Nariman S; Gibson GJ
    Thorax; 1983 Apr; 38(4):292-6. PubMed ID: 6867983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease.
    de Jong JW; Koëter GH; van der Mark TW; Postma DS
    Thorax; 1996 Jul; 51(7):684-8. PubMed ID: 8882073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilator treatment for partially reversible chronic obstructive airways disease.
    Tandon MK; Kailis SG
    Thorax; 1991 Apr; 46(4):248-51. PubMed ID: 2038732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of serial peak expiratory flow measurements in assessing treatment response in chronic airflow limitation.
    Mitchell DM; Gildeh P; Dimond AH; Collins JV
    Thorax; 1986 Aug; 41(8):606-10. PubMed ID: 3538487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.